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ABSTRACT: We used dimethylzinc to develop a conjugate addition reaction of imidomethyl radicals 
to alkylidenemalonates using dimethylzinc, in which we observed a significant difference between 
succinimidomethyl and phthalimidomethyl radicals. This reaction provides new access to γ-
aminobutyric acid derivatives, which often function as neurotransmitters. 
INTRODUCTION 
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The utility of conjugate addition in synthetic organic chemistry is well documented.1,2 We previously 
reported the dimethylzinc-mediated conjugate addition3 of α-oxygenated C-centered radicals to α,β-
unsaturated imines 4  and alkylidenemalonates. 5  Under argon atmosphere, the reaction of 
benzylidenemalonate 1a and iodomethyl pivalate provided conjugate addition product 2 as a main 
product in 94% yield within 15 min, while a subsequent aldol reaction of the zinc enolate intermediate 
with formaldehyde, which was generated by the oxidation of a pivaloyloxymethyl radical, occurred to 
give α-hydroxymethylated adduct 3 in 99% yield after 3 h in the presence of air under ordinary 
atmosphere (Scheme 1).5c As part of our continuing studies, we investigated the conjugate addition of 
imidomethyl radicals to alkylidenemalonate.6,7 It was reported that dimethylzinc-mediated conjugate 
addition of imidomethyl radicals to fumarate was followed by intramolecular addition of the resulting 
zinc enolate intermediate to the imido carbonyl group.7a In contrast, the reaction of alkylidenemalonates 
proceeded without a subsequent intramolecular reaction and provided γ-aminobutyric acid (GABA) 
derivatives with a β-substituent, which often function as neurotransmitters.8  In addition, α,β-bis 
imidomethylation occurred in good yield when an excess amount of N-iodomethylphthalimide was used 
as a radical source. Herein, we report the β-mono and α,β-bis imidomethylation of alkylidenemalonate 
using dimethylzinc-mediated conjugate addition, 9  as well as the significant difference among 
pivaloyloxymethyl, succinimidomethyl, and phthalimidomethyl radicals. 
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RESULTS AND DISCUSSION 
The reaction of benzylidenemalonate 1a and N-iodomethylsuccinimide (4a) was first conducted under 
the conditions reported for the reaction of 1a and iodomethyl pivalate.5c tert-Butyl hydroperoxide 
(TBHP) and boron trifluoride diethyl etherate (1.2 equiv each), and then dimethylzinc (3 equiv) were 
added to a solution of 1a (1 mmol) and 4a (3 equiv) in dichloromethane (5 mL), and the mixture was 
stirred at room temperature under argon atmosphere. The reaction was so sluggish that it failed to 
complete even after 24 h, giving succinimidomethyl adduct 5aa in only 18% yield along with α-
hydroxymethylated adduct 6aa (10%), with significant recovery (59%) of 1a (Table 1, entry 1). A 
plausible pathway to 6aa is shown in Scheme 2. The reaction is initiated by the action of dimethylzinc 
and oxygen or TBHP to generate a methyl radical. The methyl radical abstracts an iodine atom from 4a 
to give imidomethyl radical A, which undergoes addition to 1a. The resulting radical intermediate B is 
trapped by dimethylzinc to give zinc enolate C and a methyl radical, which restarts the chain reaction. 
As in the reaction with iodomethyl pivalate,5c the formation of 6aa is attributable to the subsequent aldol 
reaction of C with formaldehyde, which is formed by the action of imidomethyl radical A and oxygen 
that invaded into the reaction flask, via imidomethanolate D.10 
 
Table 1. Reactions of 1a with 2a.a 
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1b Me2Zn 18 10 - 59 
2 Me2Zn 51 4 7 24 
3 Et2Zn 49c - - 34 
 
4 
4 Et3B 21 - 20 6 
5d Me2Zn 78 4 4 - 
6d,e Me2Zn 92 4 3 - 
a The reaction was conducted using 1a (1 mmol) and 2a (3 equiv) with BF3·OEt2 (1.2 equiv), TBHP 
(1.2 equiv), and initiator (3 equiv) in CH2Cl2 (5 mL) unless otherwise mentioned. Suc = succinoyl b 
Under argon atmosphere for 24 h. c Ethyl adduct was produced in 6% yield. d TBHP (0.4 equiv) and 
Me2Zn (1 equiv) were added every 2 h. e The reaction was conducted in CH2Cl2 (10 mL). 
 







































This slow reaction is in great contrast to the reaction with iodomethyl pivalate, which gave 
pivaloyloxymethyl adduct 2 in 94% yield within 15 min under the same conditions (Scheme 1). The 
slow reaction seems to reflect the inferior nucleophilicity of imidomethyl radical A to that of the 
acyloxymethyl radical, and indicates difficulty in the development of its reaction with an electrophilic 
double bond as we previously experienced in the reaction with imine.11 To enhance the generation of the 
methyl radical and increase the concentration of radical A in the reaction mixture, the reaction was 
conducted in the presence of molecular oxygen under ordinary atmosphere. As expected, the reaction 
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rate increased, but was still slow, and after 6 h, produced 5aa, 6aa, and α,β-bis imidomethylated 
product 7aa in 51%, 4%, and 7% yield, respectively, with 24% recovery of 1a (entry 2). The formation 
of 7aa was due to the radical–radical coupling between radical intermediate B and radical A (Scheme 2), 
and indicates that A existed in such a concentration in the reaction mixture, probably due to the low 
nucleophilicity of the radical, that its reaction with radical intermediate B could compete with that of 
dimethylzinc with B. It is noteworthy that only a tiny amount (4%) of 6aa was produced in the presence 
of oxygen, while the reaction with iodomethyl pivalate quantitatively gave α-hydroxymethylated 
product 3 after 3 h under ordinary atmosphere (Scheme 1). This is attributable to the stability of 
imidomethanolate D, an oxidized product of A that would supply formaldehyde more slowly than the 
PivOCH2O– formed in the reaction with iodomethyl pivalate because of the inferior leaving-group 
ability of the succinimide anion compared with the pivalate anion.12 
When diethylzinc was used in place of dimethylzinc, 5aa was produced in almost the same yield 
(49%) with a small amount (6%) of ethyl adduct (entry 3). The lack of 7aa production probably 
reflected a faster trapping of the radical intermediate B with diethylzinc to form zinc enolate with 
liberation of the ethyl radical, which was more stable than the methyl radical. In the reaction with 
diethylzinc, no 4a remained in the crude mixture, and instead, a small amount (8% based on utilized 4a) 
of N-methylsuccinimide was observed, while ca. 40% of 4a remained unreacted after the reaction with 
dimethylzinc (entry 2). This is probably because the succinimidomethyl radical underwent not only 
addition to 1a but also an SH2 reaction with diethylzinc to give the succinimidomethylzinc species and 
ethyl radical, as previously documented.7a This probably contributed to reducing the concentration of the 
succinimidomethyl radical and resulted in suppressed 7aa production. The reaction with triethylborane 
gave almost the same amount of 5aa and 7aa (21% and 20% yields, respectively) with unidentified 
byproducts (entry 4). The increased production of 7aa and byproducts could be attributed to a slower 
reaction rate between radical intermediate B and triethylborane, as previously observed.5 
Based on TLC monitoring of the reaction with dimethylzinc (entry 2), the reaction proceeded 
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intensively at the beginning and rapidly became slower, and most of the dimethylzinc seemed to be 
consumed within 2 h. Therefore, radical initiators, i.e., TBHP and dimethylzinc, were added in three 
portions (0.4 × 3 and 1 × 3 equiv, respectively) at 2-h intervals. To our delight, 1a was totally consumed 
after 6 h, and 5aa, 6aa, and 7aa were obtained in 78%, 4%, and 4% yield, respectively (entry 5). The 
yield of 5aa was further improved to 92% when the reaction was conducted in a more diluted condition 
with 10 mL CH2Cl2 (entry 6; Method A). 
The scope of Method A was investigated using other alkylidenemalonates (Table 2). The reaction also 
proceeded with 1b, bearing an electron-withdrawing group, to give 5ba in 66% yield (entry 2). With 1c, 
bearing an electron-donating group, adduct 5ca was produced in 85% yield (entry 3). The reaction was 
slightly retarded with sterically hindered substrate 1d bearing an ortho-tolyl group to provide adduct 
5da in 70% yield with 8% recovery of 1d (entry 4). The reaction with aliphatic substrate 1e proceeded 
smoothly and afforded adduct 5ea in 84% yield after 2 h (entry 5).  
 






















5 % yield 
1b 1a Ph 1.2 3 6 5aa 92 
2 1b 4-ClC6H4 1.6 4 8 5ba 66c 
3 1c 4-MeOC6H4 1.6 4 8 5ca 85 
4 1d 2-MeC6H4 1.6 4 8 5da 70d 
5 1e i-Bu 0.4 1 2 5ea 84 
a Method A: TBHP (0.4 equiv) and Me2Zn (1 equiv) were added every 2 h for the indicated reaction 
time. Suc = succinoyl b Data from Table 1, entry 6 for comparison. c With 2% recovery of 1d. d With 8% 




In contrast to the reaction with 4a, that with N-iodomethylphthalimide (4b) was much faster and 
produced much more bis-imidomethylated product 7ab. When the reaction was conducted under the 
conditions shown in Table 1, entry 2 using 4b in place of 4a, 1a was completely consumed within 6 h, 
and 7ab was mainly produced in 76% yield along with adduct 5ab in 14% yield (Table 3, entry 1; 
Method B). The production of a significant amount (76%) of 7ab indicates that a high concentration of 
the phthalimidomethyl radical existed in the reaction mixture. NMR analysis of the crude mixture 
showed that a much smaller amount (9%) of 4b than 4a remained unreacted after this reaction under the 
same conditions (40% in Table 1, entry 2). These results clearly indicate that the methyl radical should 
react with 4b faster than with 4a, probably because of the higher stability of the phthalimidomethyl 
radical than of the succinimidomethyl radical. Indeed, the following isodesmic reaction indicated that 
the phthalimidomethyl radical was more stable by 1.3 kcal/mol than the succinimidomethyl radical at 
the B3LYP/6-311++G(3df,3pd)//B3LYP/6-31+G* level of theory (Scheme 3). 13  Importantly, this 
radical–radical cross-coupling occurred highly selectively, and no homo coupling products such as N,N'-
ethylenebisphthalimide were detected by 1H NMR of the crude mixture, suggesting that the 
phthalimidomethyl radical should be present in a much smaller amount in the reaction mixture than the 
radical intermediate B, the homo coupling of which could be sterically prevented.14 
 
Table 3. Reactions of 1a with 4b.a 






























1 3 Me2Zn 14 76 - 
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2 3 Et2Zn 49b 4 - 
3 3 Et3B 36 17 12 
4 1.2 Me2Zn 81 9 - 
5 1.2 Et2Zn 23c - 6 
6 1.2 Et3B 34 16 26 
a The reaction was conducted using 1a (0.5 mmol) with BF3·OEt2 (1.2 equiv), TBHP (1.2 equiv), and 
initiator (3 equiv) in CH2Cl2 (2.5 mL). Phth = phthaloyl b Ethyl adduct was produced in 37% yield. c 
Ethyl adduct was produced in 62% yield. 
 
Scheme 3. Relative Stability of Succinimidomethyl and Phthalimidomethyl Radicals at the B3LYP/6-















In contrast, the reaction using diethylzinc in place of dimethylzinc gave 5ab as a major product in 
49% yield along with ethyl adduct in 37% yield, and 7ab was a minor product in 4% yield (Table 3, 
entry 2). The decreased production of 7ab was probably due to the higher reactivity of diethylzinc 
toward the radical intermediate, corresponding to B, and toward the phthalimidomethyl radical than that 
of dimethylzinc to decrease the concentration of these radical species in the reaction mixture and 
suppress the radical–radical coupling. In this reaction, much more ethyl adduct (37%) was produced 
than that in the reaction with 4a (6% in Table 1, entry 4). These results suggest that the 
phthalimidomethyl radical was less nucleophilic and thus less competitive with the ethyl radical than the 
succinimidomethyl radical. The use of triethylborane in place of diethylzinc resulted in an increased 
production of 7ab (17%) as well as a decreased yield of 5ab (36%) with 12% recovery of 1a (Table 3, 
entry 3). The result is again attributable to the insufficient rate of the reaction between the radical 
intermediate, corresponding to B, and triethylborane.5 
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When the amount of 4b used was decreased to 1.2 equiv, the reaction mainly provided 5ab in 81% 
yield, and 7ab was produced in only 9% yield (entry 4; Method C). Therefore, the concentration of the 
imidomethyl radical in the reaction mixture seems highly dependent on the amount of iodide 4 added to 
the reaction mixture. The use of diethylzinc under this condition produced mainly ethyl adduct in 62% 
yield with 5ab in 23% yield, and 6% of 1a was recovered (entry 5). The reaction with triethylborane 
gave almost the same results (5ab in 36% and 34% yields, and 7ab in 17% and 16% yields, 
respectively) in the reactions using 3 and 1.2 equiv of 4b (entries 3 and 6). 
Using Method C or B, mono- or bis-imidomethylation was preferentially achieved with other 
alkylidenemalonates (Table 4). The reactions of benzylidenemalonate 1b bearing an electron-
withdrawing group with 1.2 or 3 equiv of 4b proceeded smoothly and mainly gave 5bb and 7bb in 83% 
and 74% yield, respectively (entries 3 and 4). With 1c bearing an electron-donating group, the product 
distribution also switched, and 5cb and 7cb were obtained in 77% and 70% yield by Methods C and B, 
respectively (entries 5 and 6). In the reaction with sterically hindered 1d, the increased amount of 4b (6 
equiv) was required to gain 7db in good yield (62%), but 5db was obtained in 61% yield with 1.2 equiv 
of 4b (entries 7 and 8). In these reactions, 14% and 10% of 1d was recovered, respectively. Mono-
imidomethylation of aliphatic substrate 1e with Method C produced 5eb in 84% yield (entry 9). 
Interestingly, even with 3 equiv of 4b, the reaction of 1e gave mainly 5eb in 68% yield, and 7eb was 
obtained as a minor product in 18% yield (entry 10). 
 
































1b 1a Ph 1.2 5ab/81 7ab/6 
2c 1a Ph 3 5ab/14 7ab/76 
3d 1b 4-ClC6H4 1.2 5bb/83 7bb/10 
4 1b 4-ClC6H4 3 5bb/22 7bb/74 
5 1c 4-MeOC6H4 1.2 5cb/77 7cb/7 
6 1c 4-MeOC6H4 3 5cb/17 7cb/70 
7e 1d 2-MeC6H4 1.2 5db/61 7db/10 
8f 1d 2-MeC6H4 6 5db/16 7db/62 
9d 1e i-Bu 1.2 5eb/84 7eb/7 
10 1e i-Bu 3 5eb/68 7eb/18 
a The reaction was conducted using 1 (0.5 mmol) with BF3·OEt2 (1.2 equiv), TBHP (1.2 equiv), and 
Me2Zn (3 equiv) in CH2Cl2 (2.5 mL) unless otherwise mentioned. Phth = phthaloyl b Data from Table 3, 
entry 1 for comparison. c Data from Table 3, entry 4 for comparison. d With 1 (2 mmol) in CH2Cl2 (10 
mL). e With 14% recovery of 1d. f With 10% recovery of 1d.  
 
The following experiment excluded the possibility that 7 was formed by an SN2 reaction of the zinc 
enolate, such as C, with imidomethyl iodide 4: The reaction of 1a was conducted under the conditions 
of Method C for 6 h, and then 3 equiv of 4b was added to the reaction mixture, in which the zinc enolate 
intermediate, corresponding to C, should have formed as a major product (Scheme 4). After additional 
stirring for 3 h, the crude product was analyzed by 1H NMR and was found to contain mono-
imidomethyl adduct 5ab and bis-imidomethylated product 7ab as a 91:9 mixture. This result clearly 
indicates that the zinc enolate is not an intermediate to give 7ab. 
 
Scheme 4. Attempted Reaction of the Zinc Enolate Intermediate with 4b. 















The competition reaction with 4a and 4b provided more information about the difference between the 
succinimidomethyl and phthalimidomethyl radicals. Boron trifluoride diethyl etherate (1.2 equiv), 
TBHP (1.2 equiv), and dimethylzinc (3 equiv) were added to the mixture of 1a (0.5 mmol), 4a, and 4b 
(3 equiv each) in dichloromethane (2.5 mL). After 6 and 8 h, additional boron trifluoride diethyl 
etherate, TBHP, and dimethylzinc (1.2, 0.4, and 1 equiv each) were added to the mixture. After 9 h in 
total, 1a was completely consumed, and 5aa, 5ab, 7ab, 7ac, and 7ad were produced in 10%, 33%, 25%, 
15%, and 3% yield, respectively (Scheme 5). Because most of radicals, including the tert-butyl radical, 
undergo radical–radical coupling at the diffusion-controlled limit, 15  the reactions of a radical 
intermediate such as B with succinimidomethyl and phthalimidomethyl radicals are likely also 
diffusion-controlled, and thus, the rate constants should be almost the same for both radicals. This 
means that the product distribution of bis-imidomethylation should be proportional to the concentration 
of the radical species in the reaction mixture. In the above reaction, although 43% of 1a was bis-
imidomethylated in total, α-phthalimidomethylation mainly occurred, giving 7ab and 7ac, and α-
succinimidomethylated adduct 7ad was produced in only 3% yield. This result indicates that the amount 
of the phthalimidomethyl radical was approximately 10-fold higher than that of the succinimidomethyl 
radical in the reaction mixture, which is in good agreement with the calculated relative stability of the 
phthalimidomethyl and succinimidomethyl radicals, corresponding to a ratio of 90:10 at 25 °C (Scheme 
3). 
 
Scheme 5. Competition Experiment between 4a and 4b (Phth = phthaloyl, Suc = succinoyl). 
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1a + 4a + 4b
BF3·OEt2 (1.2 + 1.2 x 2) equiv 
TBHP (1.2 + 0.3 x 2) equiv
Me2Zn (3 + 1 x 2) equiv
air
CH2Cl2 (0.2 M)













: R1, R2 = Suc, Phth








The conjugate addition of the succinimidomethyl radical produced 5aa and 7ac, while the conjugate 
addition of the phthalimidomethyl radical led to the formation of 5ab, 7ab, or 7ad. The ratio of the 
combined yields of 5aa and 7ac (25%) to that of 5ab, 7ab, and 7ad (61%) was 3:7 and clearly higher 
than the relative concentration of these imidomethyl radicals (approximately 1:10, vide supra). 
Therefore, the succinimidomethyl radical seems to have undergone addition to 1a approximately four 
times faster than the phthalimidomethyl radical, indicating higher nucleophilicity of the 
succinimidomethyl radical. The observed lower nucleophilicity of the phthalimidomethyl radical 
suggests that its higher stability is due to the electron-withdrawing ability of the benzene ring, which 
delocalizes the spin density of the radical. Actually, the DFT calculations indicated lower spin density at 
the reaction center of the phthlimidomethyl radical than that of the succinimidomethyl radical (0.833 
and 0.858 at the B3LYP/6-311++G(3df,3pd)//B3LYP/6-31+G* level of theory, respectively).13 It is 
interesting that 4a was a superior imidomethyl radical source than 4b in the addition reaction with N-
Boc imine to give the corresponding adduct in better yield.11c This could be attributable to the inferior 
electrophilicity of the imine16 in the reaction in which the nucleophilicity of the radical could be a more 
important factor than its concentration. 
Adducts 5bb and 5eb were readily converted into GABA analogs for medical use (Scheme 6). 
Decarboxylation and subsequent hydrolysis of 5bb and 5eb provided baclofen hydrochloride (R = 4-
ClC6H4)8a and pregabalin hydrochloride (R = i-Bu)8b in 71% and 69% yield in 2 steps, respectively. The 
treatment of bis-imidomethylated product 7bb with N2H4•H2O afforded α-aminomethyl γ-lactam 8 in 




Scheme 6. Conversion of 5bb and 5eb into GABA Analogs, and 7bb into γ-Lactam 8 
5bb or 5eb
1) LiCl, DMSO, 130 °C, 16 h

























We developed a mono- and bis-imidomethylation reaction of alkylidenemalonate with dimethylzinc-
mediated conjugate addition of imidomethyl radicals. The nucleophilicity of the phthalimidomethyl 
radical was inferior to that of the succinimidomethyl radical, but exhibited better performance in the 
conjugate addition because of its higher concentration in the reaction mixture as a result of its superior 
stability. This is a striking contrast to the reaction of imine, in which the nucleophilicity of the radicals 
was a dominant factor, and the addition of the succinimidomethyl radical proceeded more smoothly. 
Importantly, bis-imidomethylation occurred via highly selective radical–radical cross-coupling, 
probably due to the steric protection of the adduct radical intermediate toward the self-coupling. This 
provides a rare example of a highly selective and efficient radical–radical cross-coupling reaction. 
Facile conversion of the products into clinically useful GABA analogs highlights the utility of this 
reaction.  
EXPERIMENTAL SECTION 
General. All melting points were measured after recrystallization from hexane–EtOAc and are 
reported without correction. Silica gel was used for column chromatography. NMR (500 and 125 MHz 
for 1H and 13C, respectively) was measured in CDCl3 unless otherwise mentioned. Chemical shifts (δ) 
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and coupling constants (J) are presented in parts per million relative to tetramethylsilane and hertz, 
respectively. Abbreviations are as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, 
broad.13C peak multiplicity assignments were made on the basis of DEPT data. IR spectroscopy was 
recorded using an	attenuated total reflectance FTIR unless otherwise noted, and the wave numbers of 
maximum absorption peaks are reported in cm−1. Quadrupole, double-focusing magnetic sector, and 
TOF mass spectrometers were used for EI-, FAB-, and HRMS-ESI, respectively. Solvents, including 
anhydrous dichloromethane and THF, hexane solutions of dimethylzinc, diethylzinc and triethylborane, 
were purchased and used as received.  
Starting Materials. Alkylidenemalonates 1a and 1c,17 1b,18 1d,19 and 1e;20 iodides 4a and 4b11c were 
prepared according to literature procedures. 
Method A (Table 2, entry 1). Dimethyl 2-(1-Phenyl-2-succinimidoethyl)malonate (5aa), 
Dimethyl 2-Hydroxymethyl-2-(1-phenyl-2-succinimidoethyl)malonate (6aa), Dimethyl 2-(1-
Phenyl-2-succinimidoethyl)-2-succinimidomethylmalonate (7aa): A magnetic stir bar and 1a (220 
mg, 1.00 mmol) were placed in a dried 20 mL two-neck round-bottom flask that was capped with an 
argon balloon. To the flask, were added CH2Cl2 (10 mL), 4a (0.72 mg, 3.0 mmol), and a 6.6 M decane 
solution of TBHP (60 μL, 0.40 mmol) at rt. To the stirred solution cooled in an ice−water bath, were 
added BF3·OEt2 (0.16 mL, 1.2 mmol), and a 1.0 M hexane solution of Me2Zn (1.0 mL, 1.0 mmol). The 
argon balloon was replaced with a NaOH drying tube, and the cooling bath was removed. The solution 
of TBHP (60 μL, 0.40 mmol each) and the solution of Me2Zn (1.0 mL, 1.0 mmol each) were added to 
the mixture every two hours. After addition of 3.0 mmol Me2Zn in total, the mixture was stirred for 
further 2 h, and the reaction was quenched by the addition of aq saturated NH4Cl. The whole was 
extracted three times with EtOAc, and the combined organic layers were washed with sat. Na2S2O3 and 
brine, dried over Na2SO4, and then evaporated. The purification of the resulting residue by column 
chromatography (hexane/EtOAc 9:1 to 1:1) gave 5aa (306 mg, 92%) as a colorless solid of mp 
70−71 °C, 6aa (13 mg, 4%) as a white solid of mp 111−112 °C, and 7aa (12 mg, 3%) as a white solid of 
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mp 230−231 °C. 
5aa: 1H NMR: 2.47–2.52 (m, 4H), 3.43 (s, 3H), 3.78 (s, 3H), 3.81 (dd, J = 13.5, 7.0, 1H), 3.85 (d, J = 
10.5, 1H), 3.90 (dd, J = 13.5, 8.5, 1H), 4.00 (ddd, J = 10.5, 8.5, 7.0, 1H), 7.18−7.30 (m, 5H). 13C NMR 
27.9 (CH2), 41.9 (CH2), 42.4 (CH), 52.4 (CH3), 52.8 (CH3), 56.2 (CH), 127.7 (CH), 128.3 (CH), 128.4 
(CH), 137.4 (C), 167.6 (C), 168.3 (C), 176.8 (C). IR: 3020, 1736, 1701, 1435, 1404, 1215, 1165, 752. 
ESIMS (m/z): [M + H]+ calcd for C17H20NO6, 334.1285; found, 334.1285. 
6aa: 1H NMR: 2.35−2.50 (m, 4H), 2.58 (br s, 1H), 3.78 (dd, J = 13.5, 4.5, 1H), 3.78-3.82 (br m, 2H), 
3.83 (s, 3H), 3.87 (s, 3H), 3.94 (dd, J = 11.0, 4.5, 1H), 4.60 (dd, J = 13.5, 11.0, 1H), 7.14−7.16 (m, 2H), 
7.23-7.25 (m, 3H). 13C NMR: 27.8 (CH2), 40.4 (CH2), 45.7 (CH), 52.7 (CH3), 52.9 (CH3), 63.0 (C), 65.8 
(CH2), 128.1 (CH), 128.4 (CH), 129.3 (CH), 135.5 (C), 170.0 (C), 170.4 (C), 176.7 (C). IR: 3017, 1732, 
1701, 1404, 1215, 1169, 760. HRMS-ESI (m/z): [M + H]+ calcd for C18H22NO7, 364.1391; found, 
364.1389. 
7aa: 1H NMR: 2.28−2.43 (m, 4H), 2.69 (s, 4H), 3.775 (s, 3H), 3.783 (s, 3H), 3.86 (d, J = 14.5, 1H), 
3.88 (dd, J = 13.0, 4.5, 1H), 3.98 (dd, J = 11.5, 4.5, 1H), 4.18 (d, J = 14.5, 1H), 4.44 (dd, J = 13.0, 11.5, 
1H), 7.20−7.24 (m, 5H). 13C NMR: 27.7 (CH2), 28.0 (CH2), 40.3 (CH2), 41.7 (CH2), 45.6 (CH), 52.7 
(CH3), 53.1 (CH3), 59.9 (C), 128.08 (CH), 128.11 (CH), 130.0 (CH), 135.2 (C), 168.96 (C), 169.04 (C), 
176.5 (C), 176.9 (C). IR: 3017, 1732, 1705, 1400, 1215, 1165, 760. HRMS-ESI (m/z): [M + H]+ calcd 
for C22H25N2O8, 445.1605; found, 445.1606. 
Dimethyl 2-(1-(4-Chlorophenyl)-2-succinimidoethyl)malonate (5ba): Method A, using 1b (255 mg, 
1.00 mmol) in place of 1a, gave 5ba (243 mg, 66%) as a colorless solid of mp 147−148 °C: 1H NMR: 
2.52 (s, 4H), 3.47 (s, 3H), 3.75−3.80 (m, 2H), 3.77 (s, 3H), 3.90 (dd, J = 13.5, 8.5, 1H), 4.00 (ddd, J = 
10.5, 8.5, 7.5, 1H), 7.15 (d, J = 8.5, 2H), 7.24 (d, J = 8.5, 2H). 13C NMR: 27.9 (CH2), 41.6 (CH2), 41.9 
(CH), 52.6 (CH3), 52.9 (CH3), 56.0 (CH), 128.7 (CH), 129.8 (CH), 133.6 (C), 136.0 (C), 167.4 (C), 
168.0 (C), 176.7 (C). IR: 3021, 1736, 1701, 1404, 1215, 1161, 752. HRMS-ESI (m/z): [M + H]+ calcd 
for C17H19ClNO6, 368.0895; found, 368.0895. 
 
16 
Dimethyl 2-(1-(4-Methoxyphenyl)-2-succinimidoethyl)malonate (5ca): Method A, using 1c (250 
mg, 1.00 mmol) in place of 1a, gave 5ca (308 mg, 85%) as a colorless solid of mp 105−106 °C: 1H 
NMR: 2.50 (s, 4H), 3.45 (s, 3H), 3.76–3.80 (m, 2H), 3.77 (s, 6H), 3.88 (dd, J = 13.5, 8.5, 1H), 3.96 (ddd, 
J = 10.5, 8.5, 7.5, 1H), 6.79 (d, J = 8.5, 2H), 7.11 (d, J = 8.5, 2H). 13C NMR: 27.9 (CH2), 41.7 (CH), 
41.9 (CH2), 52.4 (CH3), 52.8 (CH3), 55.1 (CH3), 56.4 (CH), 113.8 (CH), 129.2 (C), 129.4 (CH), 158.9 
(C), 167.6 (C), 168.3 (C), 176.8 (C). IR: 3021, 1736, 1701, 1516, 1404, 1215, 1165, 752. HRMS-ESI 
(m/z): [M + H]+ calcd for C18H22NO7, 364.1391; found, 364.1390. 
Dimethyl 2-(2-Succinimido-1-o-tolylethyl)malonate (5da): Method A, using 1d (234 mg, 1.00 
mmol) in place of 1a, gave 5da (244 mg, 70%) as a colorless solid of mp 105−106 °C: 1H NMR: 2.41 (s, 
3H), 2.56 (s, 4H), 3.37 (s, 3H), 3.72–3.79 (m, 1H), 3.76 (s, 3H), 3.82, (dd, J = 13.5, 8.0, 1H), 3.94 (d, J 
= 10.5, 1H), 4.28 (m, 1H), 7.12−7.14 (m, 4H). 13C NMR: 19.5 (CH3), 27.9 (CH2), 37.3 (CH), 42.0 (CH2), 
52.3 (CH3), 52.8 (CH3), 56.3 (CH), 125.9 (CH), 126.6 (CH), 127.3 (CH), 130.6 (CH), 136.1 (C), 137.0 
(C), 167.7 (C), 168.6 (C), 177.0 (C). IR: 3021, 1732, 1701, 1404, 1215, 1165, 818, 752. HRMS-ESI 
(m/z): [M + H]+ calcd for C18H22NO6, 348.1442; found, 348.1441. 
Dimethyl 2-(3-Methyl-1-(succinimidomethyl)butyl)malonate (5ea): Method A, using 1e (200 mg, 
1.00 mmol) in place of 1a, gave 5ea (263 mg, 84%) as a colorless solid of mp 70−71 °C: 1H NMR: 0.89 
(d, J = 6.5, 3H), 0.91 (d, J = 6.5, 3H), 1.14 (ddd, J = 14.0, 8.5, 4.5, 1H), 1.35 (ddd, J = 14.0, 9.0, 5.5, 
1H), 1.71 (m, 1H), 2.51 (ddtd, J = 8.5, 7.0, 5.5, 5.0, 1H), 2.69 (d, J = 9.5, 2H), 2.71 (d, J = 9.5, 2H), 
3.42 (d, J = 5.5, 1H), 3.64 (dd, J = 14.0, 5.0, 1H), 3.69 (dd, J = 14.0, 7.0, 1H), 3.74 (s, 3H), 3.76 (s, 3H). 
13C NMR: 21.8 (CH3), 23.1 (CH3), 25.5 (CH), 28.1 (CH2), 35.3 (CH), 39.0 (CH2), 40.5 (CH2), 52.41 
(CH3), 52.43 (CH3), 53.7 (CH), 168.8 (C), 168.9 (C), 177.5 (C). IR: 2955, 1732, 1701, 1404, 1215, 1172, 
763. HRMS-ESI (m/z): [M + H]+ calcd for C15H24NO6, 314.1598; found, 314.1599. 
Method C (Table 4, entry 1). Dimethyl 2-(1-Phenyl-2-phthalimidoethyl)malonate (5ab): A 
magnetic stir bar and 1a (110 mg, 0.500 mmol ) were placed in a dried 10 mL two-neck round-bottom 
flask that was capped with an argon balloon. To the flask, were added CH2Cl2 (2.5 mL), 4b (0.17 g, 0.60 
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mmol), and a 5.8 M decane solution of TBHP (0.10 mL, 0.60 mmol) at rt. To the stirred solution cooled 
in an ice−water bath, were added BF3·OEt2 (80 μL, 0.60 mmol) and a 1.0 M hexane solution of Me2Zn 
(1.5 mL, 1.5 mmol). The argon balloon was replaced with a NaOH drying tube, and the cooling bath 
was removed. After 6 h, the reaction was quenched by the addition of aq saturated NH4Cl, and the 
mixture was extracted three times with EtOAc. The combined organic layers were washed with aq 
saturated Na2S2O3 and brine, dried over Na2SO4, and then evaporated. The purification of the residue by 
column chromatography (hexane/EtOAc 9:1 to 1:1) gave 5ab (157 mg including 3 mg of unidentified 
phthalimide derivatives), which was characterized after further purification by preparative TLC to give a 
colorless solid of mp 109−110 °C: 1H NMR: 3.44 (s, 3H), 3.69 (s, 3H), 3.89 (d, J = 10.0, 1H), 4.00 (m, 
1H), 4.06−4.12 (m, 2H), 7.16−7.23 (m, 5H), 7.66 (dd, J = 5.5, 3.0, 2H), 7.76 (dd, J = 5.5, 3.0, 2H). 13C 
NMR: 41.3 (CH2), 43.6 (CH), 52.4 (CH3), 52.8 (CH3), 56.0 (CH), 123.2 (CH), 127.6 (CH), 128.35 (CH), 
128.44 (CH), 131.7 (C), 133.9 (CH), 137.5 (C), 167.6 (C), 167.9 (C), 168.2 (C). IR: 3021, 1736, 1712, 
1396, 1215, 752. HRMS-ESI (m/z): [M + H]+ calcd for C21H20NO6, 382.1285; found, 382.1280. The 
yields (5ab: 81%, 7ab: 6%) were determined by 1H NMR on the basis of the integration area of the 
signals at 3.44 and 3.81 ppm, respectively, using Ph3CH (5.55 ppm) as an internal standard 
Dimethyl 2-(1-(4-Chlorophenyl)-2-Phthalimidoethyl)malonate (5bb): Method C, using 1b (509 mg, 
2.00 mmol) in place of 1a in CH2Cl2 (10 mL) with 4b (0.69 g, 2.4 mmol), the solution of TBHP (0.40 
mL, 2.4 mmol), BF3·OEt2 (0.32 mL, 2.4 mmol), and the solution of Me2Zn (6.0 mL, 6.0 mmol), gave 
5bb (688 mg, 83%) as a colorless oil: 1H NMR: 3.49 (s, 3H), 3.71 (s, 3H), 3.83 (d, J = 10.0, 1H), 3.96 
(m, 1H), 4.05−4.12 (m, 2H), 7.18 (d, J = 9.0, 2H), 7.20 (d, J = 9.0, 2H), 7.68 (dd, J = 5.5, 3.0, 2H), 7.77 
(dd, J = 5.5, 3.0, 2H). 13C NMR: 41.0 (CH2), 43.0 (CH), 52.6 (CH3), 52.9 (CH3), 55.9 (CH), 123.3 (CH), 
128.7 (CH), 129.8 (CH), 131.6 (C), 133.5 (C), 134.0 (CH), 151.6 (C), 167.4 (C), 167.8 (C), 168.0 (C). 
IR (neat): 2954, 1735, 1716, 1435, 1396, 721. HRMS-ESI (m/z): [M + H]+ calcd for C21H19ClNO6, 
416.0895; found, 416.0897. The yield of 7bb (10%) was determined by 1H NMR of the crude mixture 




Dimethyl 2-(1-(4-Methoxyphenyl)-2-phthalimidoethyl)malonate (5cb): Method C, using 1c (125 
mg, 0.500 mmol) in place of 1a, gave 5cb (167 mg including 9 mg of unidentified phthalimide 
derivatives), which was characterized after further purification by preparative TLC: a colorless oil. 1H 
NMR: 3.47 (s, 3H), 3.69 (s, 3H), 3.73 (s, 3H), 3.83 (d, J = 10.0, 1H), 3.96 (m, 1H), 4.02−4.10 (m, 2H), 
6.75 (d, J = 8.5, 2H), 7.15 (d, J = 8.5, 2H), 7.66 (dd, J = 5.5, 3.0, 2H), 7.76 (dd, J = 5.5, 3.0, 2H). 13C 
NMR: 41.3 (CH2), 42.8 (CH), 52.4 (CH3), 52.7 (CH3), 55.1 (CH3), 56.3 (CH), 113.8 (CH), 123.2 (CH), 
129.35 (C), 129.44 (CH), 131.7 (C), 133.9 (CH), 158.8 (C), 167.7 (C), 167.9 (C), 168.3 (C). IR (neat): 
2954, 1736, 1713, 1516, 1250, 725. HRMS-ESI (m/z): [M + H]+ calcd for C22H22NO7, 412.1391; found, 
412.1394. The yields (5cb: 77%, 7cb: 7%) were determined by 1H NMR on the basis of the integration 
area of the signals at 3.47 and 3.71 ppm, respectively, using Ph3CH (5.55 ppm) as an internal standard. 
Dimethyl 2-(2-Phthalimido-1-o-tolylethyl)malonate (5db): Method C, using 1d (117 mg, 0.500 
mmol) in place of 1a, gave 5db (135 mg including 15 mg of unidentified phthalimide derivatives), 
which was characterized after further purification by preparative TLC to give a colorless oil: 1H NMR: 
2.42 (s, 3H), 3.39 (s, 3H), 3.62 (s, 3H), 3.93−4.02 (m, 3H), 4.41 (dt, J = 10.5, 7.0, 1H), 7.05−7.14 (m, 
3H), 7.20 (d, J = 7.5, 1H), 7.68 (dd, J = 5.5, 3.0, 2H), 7.79 (dd, J = 5.5, 3.0, 2H). 13C NMR: 19.6 (CH3), 
41.2 (CH2), 52.4 (CH3), 52.7 (CH3), 56.0 (CH), 123.2 (CH), 126.0 (CH), 127.3 (CH), 130.6 (CH), 131.8 
(C), 133.9 (CH), 136.2 (C), 137.1 (C), 167.8 (C), 168.0 (C), 168.4 (C). IR (neat): 2990, 1736, 1713, 
1215, 903, 756, 725. HRMS-ESI (m/z): [M + H]+ calcd for C22H22NO6, 396.1442; found, 396.1441. The 
yields (5db: 61%, 7db: 10%) were determined by 1H NMR on the basis of the integration area of the 
signals at 3.39 and 3.77 ppm, respectively, using Ph3CH (5.55 ppm) as an internal standard. 
Dimethyl 2-(3-Methyl-1-(phthalimidomethyl)butyl)malonate (5eb): Method C, using 1e (400 mg, 
2.00 mmol) in place of 1a in CH2Cl2 (10 mL) with 4b (0.69 g, 2.4 mmol), the solution of TBHP (0.40 
mL, 2.4 mmol), BF3·OEt2 (0.32 mL, 2.4 mmol), and the solution of Me2Zn (6.0 mL, 6.0 mmol), gave 
5eb (607 mg, 84%) as a colorless oil: 1H NMR: 0.90 (d, J = 6.5, 3H), 0.93 (d, J = 6.5, 3H), 1.19 (ddd, J 
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= 14.5, 8.5, 4.5, 1H), 1.42 (ddd, J = 14.5, 8.5, 5.5, 1H), 1.77 (m, 1H), 2.63 (ddddd, J = 8.5, 7.0, 6.0, 5.5, 
4.5, 1H), 3.49 (d, J = 6.0, 1H), 3.71 (s, 3H), 3.76 (s, 3H), 3.83 (dd, J = 14.0, 5.5, 1H), 3.87 (dd, J = 14.0, 
7.0, 1H), 7.73 (dd, J = 5.5, 3.0, 2H), 7.85 (dd, J = 5.5, 3.0, 2H). 13C NMR: 21.9 (CH3), 23.1 (CH3), 25.6 
(CH), 36.2 (CH), 38.8 (CH2), 39.7 (CH2), 52.4 (CH3), 53.4 (CH), 123.3 (CH), 131.9 (C), 134.0 (CH), 
168.6 (C), 168.9 (C), 169.0 (C). IR (KBr): 2954, 1713, 1435, 1396, 1157, 725. HRMS-ESI (m/z): [M + 
H]+ calcd for C19H24NO6, 362.1598; found, 362.1598. The yield of 7eb (7%) was determined by 1H 
NMR of the crude mixture on the basis of the integration area of the signal at 4.47 ppm, using Ph3CH 
(5.55 ppm) as an internal standard. 
Method B (Table 4, entry 2). Dimethyl 2-(1-Phenyl-2-phthalimidoethyl)-2-phthalimidometh-
ylmalonate (5ab). A magnetic stir bar and 1a (110 mg, 0.500 mmol) were placed in a dried 10 mL two-
neck round-bottom flask that was capped with an argon balloon. To the flask, were added CH2Cl2 (2.5 
mL), 4b (0.43 g, 1.5 mmol), and a 5.8 M decane solution of TBHP (0.10 mL, 0.60 mmol) at rt. To the 
stirred solution cooled in an ice−water bath, were added BF3·OEt2 (80 μL, 0.60 mmol) and a 1.0 M 
hexane solution of Me2Zn (1.5 mL, 1.5 mmol). The argon balloon was replaced with a NaOH drying 
tube, and the cooling bath was removed. After 6 h, the reaction was quenched by the addition of aq 
saturated NH4Cl, and the mixture was extracted three times with EtOAc. The combined organic layers 
were washed with aq saturated Na2S2O3 and brine, dried over Na2SO4, and then evaporated. The 
purification of the residue by column chromatography (hexane/EtOAc 9:1 to 1:1) gave 7ab (625 mg 
including 417 mg of unidentified phthalimide derivatives), which was characterized after further 
purification by preparative TLC to give a white solid of mp 174−175 °C: 1H NMR: 3.81 (s, 3H), 3.84 (s, 
3H), 4.03 (d, J = 14.5, 1H), 4.12−4.19 (m, 2H), 4.32 (d, J = 14.5, 1H), 4.63 (m, 1H), 7.17−7.30 (m, 5H), 
7.60 (dd, J = 5.5, 3.0, 2H), 7.68 (dd, J = 5.5, 3.0, 2H), 7.71 (dd, J = 5.5, 3.0, 2H), 7.83 (dd, J = 5.5, 3.0, 
2H). 13C NMR: 40.2 (CH2), 41.4 (CH2), 47.2 (CH), 52.7 (CH3), 53.1 (CH3), 60.6 (C), 123.0 (CH), 123.4 
(CH), 128.1 (CH), 128.2 (CH), 129.9 (CH), 131.6 (C), 131.8 (C), 133.7 (CH), 134.0 (CH), 135.3 (C), 
167.7 (C), 167.9 (C), 169.1 (C), 169.2 (C). IR: 3021, 1775, 1717, 1396, 1215, 752. HRMS-ESI (m/z): 
 
20 
[M + H]+ calcd for C30H25N2O8, 541.1605; found, 541.1605. The yields (5ab: 14%, 7ab: 76%) were 
determined by 1H NMR on the basis of the integration area of the signals at 3.44 and 3.81 ppm, 
respectively, using Ph3CH (5.55 ppm) as an internal standard.  
Dimethyl 2-(1-(4-Chlorophenyl)-2-phthalimidoethyl)-2-phthalimidomethylmalonate (7bb): 
Method B, using 1b (127 mg, 0.500 mmol) in place of 1a, gave 7bb as (521 mg including 308 mg of 
unidentified phthalimide derivatives, 74%), which was characterized after further purification by 
preparative TLC to give a colorless solids of mp 84−85 °C: 1H NMR: 3.80 (s, 3H), 3.83 (s, 3H), 4.02 (d, 
J = 14.5, 1H), 4.14 (dd, J = 13.5, 4.0, 1H), 4.19 (dd, J = 11.5, 4.0, 1H), 4.35 (d, J = 14.5, 1H), 4.61 (dd, 
J = 13.5, 11.5, 1H), 7.17 (d, J = 8.5, 2H), 7.29 (d, J = 8.5, 2H), 7.63 (dd, J = 5.5, 3.0, 2H), 7.69 (dd, J = 
5.5, 3.0, 2H), 7.73 (dd, J = 5.5, 3.0, 2H), 7.85 (dd, J = 5.5, 3.0, 2H). 13C NMR: 39.8 (CH2), 41.1 (CH2), 
46.3 (CH), 52.8 (CH3), 53.2 (CH3), 60.6 (C), 123.1 (CH), 123.5 (CH), 128.4 (CH), 131.46 (CH), 131.54 
(C), 131.8 (C), 133.8 (CH), 133.9 (C), 134.0 (C), 134.2 (CH), 167.7 (C), 168.0 (C), 168.9 (C × 2). IR: 
3021, 1775, 1717, 1396, 1215, 748. HRMS-ESI (m/z): [M + H]+ calcd for C30H24ClN2O8, 575.1216; 
found, 575.1221. The yields (5bb: 22%, 7bb: 74%) were determined by quantitative 1H NMR on the 
basis of the integration area of the signals at 3.49 and 3.80 ppm, respectively, using Ph3CH (5.55 ppm) 
as an internal standard. 
Dimethyl 2-(1-(4-Methoxyphenyl)-2-phthalimidoethyl)-2-phthalimidomethylmalonate (7cb): 
Method C, using 1c (125 mg, 0.500 mmol) in place of 1a, gave 7cb (321 mg including 121 mg of 
unidentified phthalimide derivatives), which was characterized after further purification by preparative 
TLC to give a white solids of mp 166−167 °C. Method C using 1c (125 mg, 0.500 mmol) in place of 1a, 
gave 7cb (321 mg including 121 mg of unidentified phthalimide derivatives), which was characterized 
after further purification by preparative TLC to give a white solids of mp 166−167 °C: 1H NMR: 3.71 (s, 
3H), 3.80 (s, 3H), 3.83 (s, 3H), 4.01 (d, J = 14.5, 1H), 4.10 (dd, J = 13.5, 4.0, 1H), 4.15 (dd, J = 11.0, 
4.0, 1H), 4.32 (d, J = 14.5, 1H), 4.62 (dd, J = 13.5, 11.0, 1H), 6.73 (d, J = 9.0, 2H), 7.22 (d, J = 9.0, 2H), 
7.61 (dd, J = 5.5, 3.0, 2H), 7.69 (dd, J = 5.5, 3.0, 2H), 7.72 (dd, J = 5.5, 3.0, 2H), 7.84 (dd, J = 5.5, 3.0, 
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2H). 13C NMR: 40.0 (CH2), 41.3 (CH2), 46.3 (CH), 52.6 (CH3), 53.1 (CH3), 55.0 (CH3), 60.7 (C), 113.6 
(CH), 123.0 (CH), 123.4 (CH), 126.9 (C), 131.0 (CH), 131.7 (C), 131.8 (C), 133.6 (CH), 134.0 (CH), 
159.1 (C), 167.8 (C), 168.0 (C), 169.1 (C), 169.2 (C). IR: 3021, 1721, 1501, 1215, 745. HRMS-ESI 
(m/z): [M + H]+ calcd for C31H27N2O9, 571.1711; found, 571.1716. The yields (5cb: 17%, 7cb: 70%) 
were determined by 1H NMR on the basis of the integration area of the signals at 3.47 and 3.71 ppm, 
respectively, using Ph3CH (5.55 ppm) as an internal standard. 
Dimethyl 2-(2-Phthalimido-1-o-tolylethyl)-2-phthalimidomethylmalonate (7db): Method C, using 
1d (117 mg, 0.500 mmol) and 4b (0.86 g, 3.0 mmol) in place of 1a and 4b (1.5 mmol), gave 7db (239 
mg including 68 mg of unidentified phthalimide derivatives, 62%), which was characterized after 
further purification by preparative TLC to give a colorless solid of mp 214−215 °C: 1H NMR: 2.15 (s, 
3H), 3.77 (s, 3H), 3.87 (s, 3H), 4.07 (d, J = 14.5, 1H), 4.15 (dd, J = 13.5, 3.5, 1H), 4.23 (d, J = 14.5, 1H), 
4.47 (dd, J = 11.0, 3.5, 1H), 4.55 (dd, J = 13.5, 11.0, 1H), 6.95 (d, J = 7.5, 1H), 7.08 (t, J = 7.5, 1H), 
7.21 (t, J = 7.5, 1H), 7.35 (d, J = 7.5, 1H), 7.63 (dd, J = 5.5, 3.0, 2H), 7.69 (dd, J = 5.5, 3.0, 2H), 7.71 
(dd, J = 5.5, 3.0, 2H), 7.81 (dd, J = 5.5, 3.0, 2H). 13C NMR: 20.1 (CH3), 41.0 (CH2), 41.4 (CH2), 42.1 
(CH), 52.6 (CH3), 53.2 (CH3), 61.0 (C), 123.1 (CH), 123.3 (CH), 126.5 (CH), 127.7 (CH), 128.2 (CH), 
130.5 (CH), 131.7 (C), 131.9 (C), 133.8 (CH), 134.0 (CH), 134.4 (C), 137.7 (C), 167.8 (C × 2), 169.1 
(C), 169.7 (C). IR: 2955, 1717, 1396, 1246, 910, 725. HRMS-ESI (m/z): [M + H]+ calcd for C31H27N2O8, 
555.1762; found, 555.1763. The yields (5db: 16%, 7db: 62%) were determined by 1H NMR on the basis 
of the integration area of the signals at 3.39 and 3.77 ppm, respectively, using Ph3CH (5.55 ppm) as an 
internal standard. 
Dimethyl 2-(3-Methyl-1-phthalimidomethylbutyl)-2-phthalimidomethylmalonate (7eb): Method 
C, using 1e (117 mg, 0.500 mmol) in place of 1a, gave 7eb (256 mg including 209 mg of unidentified 
phthalimide derivatives, 18%), which was characterized after further purification by preparative TLC to 
give a colorless oil: 1H NMR: 0.81 (d, J = 6.5, 3H), 0.86 (d, J = 6.5, 3H), 1.34 (ddd, J = 14.0, 9.5, 2.0, 
1H), 1.54 (ddd, J = 14.0, 9.0, 4.5, 1H), 1.63 (m, 1 H), 2.65 (dddd, J = 9.0, 7.0, 5.5, 2.0, 1H), 3.69 (s, 3H), 
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3.70 (s, 3H), 4.04 (dd, J = 14.5, 5.5, 1H), 4.08 (dd, J = 14.5, 7.0, 1H), 4.43 (d, J = 14.5, 1H), 4.52 (d, J = 
14.5, 1H), 7.719 (dd, J = 5.5, 3.0, 2H), 7.724 (dd, J = 5.5, 3.0, 2H), 7.85 (dd, J = 5.5, 3.0, 2H), 7.86 (dd, 
J = 5.5, 3.0, 2H). 13C NMR: 21.5 (CH3), 23.7 (CH3), 27.2 (CH), 38.5 (CH), 39.5 (CH2), 39.8 (CH2), 40.4 
(CH2), 52.7 (CH3), 52.8 (CH3), 60.8 (C), 123.3 (CH), 123.5 (CH), 131.9 (C), 132.0 (C), 134.0 (CH), 
134.1 (CH), 168.3 (C), 168.6 (C), 169.4 (C), 169.5 (C). IR: 2958, 1774, 1716, 1465, 1431, 1396, 1261, 
1215. HRMS-ESI (m/z): [M + H]+ calcd for C28H29N2O8, 521.1918; found, 521.1921. The yields (5eb: 
68%, 7eb: 18%) were determined by 1H NMR on the basis of the integration area of the signals at 3.71 
and 4.47 ppm, respectively, using Ph3CH (5.55 ppm) as an internal standard. 
Competition Experiment of 4a and 4b (Scheme 5): A magnetic stir bar and 1a (110 mg, 0.500 
mmol) were placed in a dried 20 mL two-neck round-bottom flask that was capped with an argon 
balloon. To the flask, were added CH2Cl2 (2.5 mL), 4a (0.36 g, 1.50 mmol), 4b (0.43 g, 1.50 mmol), and 
a 5.8 M decane solution of TBHP (0.10 mL, 0.60 mmol) at rt. To the stirred solution cooled in an 
ice−water bath, were added BF3·OEt2 (80 μL, 0.60 mmol) and a 1.0 M hexane solution of Me2Zn (1.5 
mL, 1.5 mmol). The argon balloon was replaced with a NaOH drying tube, and the cooling bath was 
removed. After 6 and 8 h, to the stirred solution were added a 5.8 M decane solution of TBHP (0.10 mL, 
0.60 mmol), BF3·OEt2 (80 μL, 0.60 mmol) and a 1.0 M hexane solution of Me2Zn (1.5 mL, 1.5 mmol) 
respectively. After 10 h in total, the reaction was quenched by the addition of aq saturated NH4Cl, and 
the mixture was extracted three times with EtOAc. The combined organic layers were washed with aq 
saturated Na2S2O3 and brine, dried over Na2SO4, and then evaporated. The yields (5aa: 10%, 5ab: 33%, 
7aa: 0%, 7ab: 25%, 7ac: 15%, 7ad: 3%) were determined by quantitative 1H NMR on the basis of the 
integration area of the signals at 2.49, 3.44, 3.78, 3.84, 4.30 and 2.70 ppm, respectively, using Ph3CH 
(5.55 ppm) as an internal standard. 
Preparation of Authentic Samples of 7ac and 7ad. Dimethyl 2-(1-Phenyl-2-succinimidoethyl)-2-
phthalimidomethylmalonate (7ac): A mixture of 5aa (33.0 mg, 0.100 mmol) and NaH (44 mg, 0.11 
mmol) in DMSO (1 mL) were stirred for 1 h. Then, 4b (34 mg, 0.12 mmol) was added to the mixture, 
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and the mixture was heated at 50 °C for 22 h. After addition of water, the mixture was extracted three 
times with Et2O. The combined organic layers were washed with water three times and brine, dried over 
Na2SO4, and then evaporated. The purification of the residue by column chromatography 
(hexane/EtOAc 2:1) gave 7ac (4.9 mg, 10%) as a pale yellow solid of mp 179−180 °C: 1H NMR: 
2.27−2.44 (m, 4H), 3.77 (s, 3H), 3.81 (s, 3H), 3.96 (dd, J = 13.5, 4.0, 1H), 4.00 (d, J = 14.5, 1H), 4.13 
(dd, J = 11.5, 4.0 1H), 4.30 (d, J = 14.5, 1H), 4.49 (dd, J = 13.5, 11.5, 1H), 7.23−7.28 (m, 5H), 7.71 (dd, 
J = 5.5, 3.0, 2H), 7.83 (dd, J = 5.5, 3.0, 2H). 13C NMR: 27.7 (CH2), 40.3 (CH2), 41.3 (CH2), 45.8 (CH), 
52.7 (CH3), 53.1 (CH3), 60.4 (C), 123.4 (CH), 128.15 (CH), 128.19 (CH), 130.1 (CH), 131.8 (C), 134.1 
(CH), 135.1 (C), 168.0 (C), 169.0 (C), 176.6 (C × 2). IR: 2920, 2845, 1367, 1775, 1719, 1383, 1248, 
1084, 721. HRMS-ESI (m/z): [M + H]+ calcd for C26H25N2O8, 493.1605; found, 493.1604. 
Dimethyl 2-(1-Phenyl-2-phthalimidoethyl)-2-succinimidomethylmalonate (7ad): The above 
procedure using 5ab (38.1 mg, 0.100 mmol) and 4a (29 mg, 0.12 mmol) in place of 5aa and 4b gave 
7ad (15 mg, 28%) as a white solid of mp 182−183 °C: 1H NMR: 2.70 (s, 4H), 3.81 (s, 3H), 3.82 (s, 3H), 
3.88 (d, J = 14.0, 1H), 4.04 (dd, J = 11.5, 4.0, 1H), 4.07 (dd, J = 13.5, 4.0, 1H), 4.19 (d, J = 14.0, 1H), 
4.58 (dd, J = 13.5, 11.5, 1H), 7.16−7.20 (m, 3H), 7.24−7.26 (m, 2H), 7.61 (dd, J = 5.5, 3.0, 2H), 7.68 
(dd, J = 5.5, 3.0, 2H). 13C NMR: 28.0 (CH2), 40.2 (CH2), 41.7 (CH2), 46.9 (CH), 52.7 (CH3), 53.1 (CH3), 
60.1 (C), 123.0 (CH), 128.1 (CH), 128.2 (CH), 129.9 (CH), 131.6 (C), 133.7 (CH), 135.3 (C), 169.0 (C), 
169.2 (C), 176.9 (C × 2). IR: 2955, 1932, 2252, 1775, 1713, 1396, 1250, 910, 733. HRMS-ESI (m/z): 
[M + H]+ calcd for C26H25N2O8, 493.1605; found, 493.1607. 
Scheme 6. Baclofen Hydrochloride: A mixture of 5bb (703 mg, 1.66 mmol) and LiCl (141 mg, 3.32 
mmol) in DMSO (2.5 mL) was heated at 130 °C for 19 h. After addition of water, the mixture was 
extracted with CHCl3 five times. The combined organic layers were washed with brine, dried over 
Na2SO4, and then evaporated. The purification of the residue by column chromatography 
(hexane/EtOAc 9:1 to 5:2) gave methyl 3-(4-chlorophenyl)-4-phthalimidobutanoate (247 mg, 42%) as a 




Methyl 3-(4-Chlorophenyl)-4-phthalimidobutanoate: 1H NMR: 2.69 (dd, J = 16.0, 8.5, 1H), 2.74 (dd, 
J = 16.0, 6.0, 1H), 3.51 (s, 3H), 3.74 (dtd, J = 8.5, 7.5, 6.0, 1H), 3.86 (dd, J = 13.5, 7.5, 1H), 3.90 (dd, J 
= 13.5, 7.5, 1H), 7.21 (d, J = 8.5, 2H), 7.25 (d, J = 8.5, 2H), 7.71 (dd, J = 5.5, 3.0, 2H), 7.80 (dd, J = 5.5, 
3.0, 2H). 13C NMR: 38.2 (CH2), 40.1 (CH), 42.8 (CH2), 51.7 (CH3), 123.3 (CH), 128.8 (CH), 129.0 (CH), 
131.7 (C), 133.0 (C), 134.0 (CH), 138.8 (C), 168.0 (C), 171.6 (C). IR (neat): 2949, 1736, 1713, 1396, 
719, 530. HRMS-ESI (m/z): [M + H]+ calcd for C19H17ClNO4, 358.0841; found, 358.0843.  
3-(4-Chlorophenyl)-4-phthalimidobutanoic Acid: 1H NMR: 2.70 (dd, J = 16.5, 8.5, 1H), 2.75 (dd, J = 
16.5, 6.5, 1H), 3.70 (tdd, J = 8.5, 7.0, 6.5, 1H), 3.85 (dd, J = 13.5, 8.5, 1H), 3.88 (dd, J = 13.5, 7.0, 1H), 
7.20 (d, J = 8.5, 2H), 7.25 (d, J = 8.5, 2H), 7.70 (dd, J = 5.5, 3.0, 2H), 7.80 (dd, J = 5.5, 3.0, 2H). 13C 
NMR: 37.9 (CH2), 39.8 (CH), 42.7 (CH2), 123.4 (CH), 128.8 (CH), 129.0 (CH), 131.6 (C), 133.1 (C), 
134.1 (CH), 138.4 (C), 168.1 (C), 176.7 (C). IR: 3013, 1736, 1713, 1396, 910, 737. HRMS-ESI (m/z): 
[M + H]+ calcd for C18H15ClNO4, 344.0684; found, 344.0689. 1H and 13C NMR were consistent with 
those reported.21 
A mixture of the methyl ester (150 mg, 0.42 mmol), the carboxylic acid (124 mg, 0.36 mmol), and 6 
N HCl (14 mL) was heated under reflux for 13 h and cooled in an ice–water bath. The precipitated 
phthalic acid was filtered off, and the filtrate was evaporated to dryness. The resulting solids were 
suspended in cold water (10 mL) and filtered to remove insoluble materials. The filtrate was evaporated 
to dryness under reduced pressure to afford baclofen hydrochloride (139 mg, 71%) as a yellow solids of 
mp 145–146 °C, lit 183–184 °C22a and 198–200 °C:22b 1H NMR (D2O): 2.68 (dd, J = 16.0, 9.0, 1H), 2.79 
(dd, J = 16.0, 6.0, 1H), 3.18 (dd, J = 13.0, 10.0, 1H), 3.31 (dd, J = 13.0, 5.0, 1H), 3.36 (dddd, J = 10.0, 
9.0, 6.0, 5.0, 1H), 7.27 (d, J = 8.5, 2H), 7.37 (d, J = 8.5, 2H). The 1H NMR data were identical to those 
reported previously.23  
Pregabain Hydrocholide: A mixture of 5eb (607 mg, 1.68 mmol) and LiCl (156 mg, 3.68 mmol) in 
DMSO (2.5 mL) was heated at 130 °C for 19 h. After addition of water, the mixture was extracted with 
 
25 
CHCl3 five times. The combined organic layers were washed with brine, dried over Na2SO4, and then 
evaporated. The purification of the residue by column chromatography (hexane/EtOAc 9:1 to 5:2) gave 
methyl 5-methyl-3-(phthalimidomethyl)hexanoate (255 mg, 50%) as a brown oil and 5-methyl-3-
(phthalimidomethyl)hexanoic acid (91 mg, 19%) as a pale yellow solid of mp 113.0−114.0 °C. 
Methyl 5-Methyl-3-(phthalimidomethyl)hexanoate: 1H NMR: 0.90 (d, J = 6.5, 3H), 0.96 (d, J = 6.5, 
3H), 1.16-1.28 (m, 2H), 1.74 (m, 1H), 2.28 (dd, J = 16.0, 6.5, 1H), 2.34 (dd, J = 16.0, 6.5, 1H), 2.47 (m, 
1H), 3.55 (s, 3H), 3.62 (dd, J = 13.5, 8.5, 1H), 3.70 (dd, J = 13.5, 5.0, 1H), 7.72 (dd, J = 5.5, 3.0, 2H), 
7.85 (dd, J = 5.5, 3.0, 2H). 13C NMR: 22.5 (CH3), 22.7 (CH3), 25.3 (CH), 32.7 (CH), 37.5 (CH2), 41.8 
(CH2), 41.9 (CH2), 51.4 (CH3), 123.2 (CH), 132.0 (C), 133.9 (CH), 168.6 (C), 172.9 (C). IR: 2957, 1713, 
1398, 1384, 1084, 912, 733. HRMS-ESI (m/z): [M + H]+ calcd for C17H22NO4, 304.1543; found, 
304.1542. 
5-Methyl-3-(phthalimidomethyl)hexanoic Acid: 1H NMR: 0.90 (d, J = 6.5, 3H), 0.95 (d, J = 6.5, 3H), 
1.18–1.28 (m, 2H), 1.75 (m, 1H), 2.28 (dd, J = 16.0, 6.5, 1H), 2.35 (dd, J = 16.0, 6.5, 1H), 2.43 (m, 1H), 
3.63 (dd, J = 13.5, 8.5, 1H), 3.71 (dd, J = 13.5, 5.0, 1H), 7.71 (dd, J = 5.5, 3.0, 2H), 7.85 (dd, J = 5.5, 
3.0, 2H). 13C NMR: 22.5 (CH3), 22.7 (CH3), 25.2 (CH), 32.6 (CH), 37.2 (CH2), 41.7 (CH2), 123.3 (CH), 
131.9 (C), 134.0 (CH), 168.7 (C), 177.3 (C). IR (KBr): 2955, 1709, 1396, 910, 729. HRMS-ESI (m/z): 
[M + H]+ calcd for C16H20NO4, 290.1387; found, 290.1387. 
A mixture of the methyl ester (152 mg, 0.502 mmol), the carboxylic acid (57.8 mg, 0.200 mmol), and 
6 N HCl (14 mL) was heated under reflux for 13 h, and cooled in an ice–water bath. The precipitated 
phthalic acid was filtered off, and the filtrate was evaporated to dryness. The resulting solids were 
suspended in cold water (10 mL) and filtered to remove insoluble materials. The filtrate was evaporated 
to dryness under reduced pressure to afford pregabain hydrocholide (139 mg, quant) as a pale yellow 
solid of mp 113−114 °C: 1H NMR (D2O): 0.80 (d, J = 6.5, 3H), 0.82 (d, J = 6.5, 3H), 1.17 (dd, J = 7.5, 
7.0, 2H), 1.57 (t septet, J = 7.5, 6.5, 1H), 2.17 (ttd, J = 7.0, 6.5, 6.0, 1H), 2.36 (dd, J = 16.5, 7.0, 1H), 




Methyl (RS,RS)-3-Aminomethyl-4-(4-chlorophenyl)-2-oxopyrrolidine-3-carboxylate (8): A 
mixure of 7bb (115 mg, 0.200 mmol) and N2H4H2O (0.10 mL, 2.0 mmol) in MeOH/THF (1.5 mL + 
2.5 mL) was stirred at rt for 17 h. The resulting solids were removed by filtration, and the filtrate was 
evaporated. To the residue, was added 2N HCl, and the whole was washed with CHCl3 three times. The 
aqueous layer was basified by 1N NaOH, and extracted with CHCl3 three times. The combined organic 
layers were dried over Na2SO4 and evaporated to give 8 (28 mg, 50%) as a white solid of mp 
138−139 °C: 1H NMR: 2.94 (d, J = 13.5, 1H), 3.43 (d, J = 13.5, 1H), 3.50 (s, 3H), 3.63 (dd, J = 9.5, 8.0, 
1H), 3.85 (t, J = 9.5, 1H), 4.03 (dd, J = 9.5, 8.0, 1H), 6.77 (br s, 1H), 7.15 (d, J = 8.5, 2H), 7.31 (d, J = 
8.5, 2H). 13C NMR: 42.6 (CH2), 44.4 (CH2), 45.4 (CH), 52.1 (CH3), 62.0 (C), 128.8 (CH), 129.4 (CH), 
133.8 (C), 134.8 (C), 169.4 (C), 174.6 (C). IR: 3341, 3021, 1728, 1697, 1215, 748. HRMS-ESI (m/z): 
[M + H]+ calcd for C13H16ClN2O3, 283.0844; found, 283.0840. Recrystallization from hexane–ethyl 
acetate gave colorless platelets suitable for X-ray crystal structural analysis, which confirmed the 
relative configuration. The CIF file is available as a separate file in the supporting information. 
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